MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
21.17
+0.34 (1.63%)
At close: Apr 2, 2026, 4:00 PM EDT
21.17
0.00 (0.00%)
After-hours: Apr 2, 2026, 4:10 PM EDT
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $931.99 million as of April 2, 2026.
Market Cap
931.99M
Enterprise Value
632.69M
1-Year Change
n/a
Ranking
Category
Stock Price
$21.17
Market Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $931.99M, an increase of 32.33%. That is a compound annual growth rate of 92.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 917.02M | 19.63% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 977.88M |
| Aktis Oncology | 943.56M |
| UroGen Pharma | 922.04M |
| Xencor | 918.93M |
| GH Research | 913.07M |
| Fortrea Holdings | 889.19M |
| Arbutus Biopharma | 883.56M |
| Janux Therapeutics | 882.67M |